CanCEASE + Health Navigator for Smoking Cessation (CanCEASE-2 Trial)

N/A

Waitlist Available

Led By Olivier Drouin, MD, MSc, MPH

Research Sponsored by St. Justine's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to help parents who smoke quit in order to reduce children's exposure to second-hand smoke. The study will recruit 1000 participants from pediatric clinics in Montreal over 2.5 years

Who is the study for?

This trial is for parents or legal guardians who smoke, are over 18 years old, and accompany a child under 18 to pediatric clinics in Montreal. They must face at least one social challenge like job security or food access and speak French or English well enough for interviews.

What is being tested?

The study tests a smoking cessation program called CanCEASE with added Health Navigator support against usual care. Participants will be split into two groups: one receives the intervention immediately, while the other gets it after a year, with follow-ups at 6 and 12 months.

What are the potential side effects?

Since this trial involves behavioral support rather than medication, there may not be direct side effects as seen with drugs. However, participants might experience stress or anxiety related to lifestyle changes during their attempt to quit smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Aim 1 - 7-day abstinence

Aim 1 - Anabasine-confirmed quit

Aim 1 - Cotinine-confirmed quit

+12 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CanCEASE with Health NavigatorExperimental Treatment1 Intervention

Participants assigned to this arm will receive smoking cessation resources, including instructions to access Nicotine Replacement Therapy (NRT) at Baseline, 6 and 12 months. They will also have the choice to schedule support sessions with a Health Navigator, which will be an individual with lived experience related to tobacco and trained to provide support for unmet social needs.

Group II: Care-as-usualActive Control1 Intervention

Participants assigned to this group will receive care as usually delivered in participating clinics and list of smoking cessation resources, including instructions to access Nicotine Replacement Therapy (NRT).

Do I qualify?Apply below to find out